A Study of the Pan-KRAS Inhibitor LY4066434 in Participants With KRAS Mutant Solid Tumors
Eli Lilly and Company
Eli Lilly and Company
Pfizer
Revolution Medicines, Inc.
Seagen Inc.
Pfizer
Accent Therapeutics
Novartis
Novartis
Chongqing Precision Biotech Co., Ltd
Elicio Therapeutics
Medicine Invention Design, Inc
GILongevity
Amal Therapeutics
Hutchmed
UTC Therapeutics Inc.
Corvus Pharmaceuticals, Inc.
Chongqing Precision Biotech Co., Ltd
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Novartis
MacroGenics
Targovax ASA
Adlai Nortye Biopharma Co., Ltd.
Gilead Sciences
Array BioPharma
TG Therapeutics, Inc.
Novartis
Novadaq Technologies ULC, now a part of Stryker
SillaJen, Inc.
Eli Lilly and Company
Amgen
Light Sciences LLC